<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25894983</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>03</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1435-4373</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2015</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
                <ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1437-41</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-015-2370-5</ELocationID>
            <Abstract>
                <AbstractText>Recent products of piperacillin/tazobactam (PTZ) from the original manufacturer, previously considered a major cause of galactomannan (GM) false-positivity, are reported not to be related to it. However, data regarding generic PTZ are limited and controversial. To evaluate the effect of generic PTZ on GM false-positivity in Korea, we performed a case-control study in adult patients with cancer. A case-control study was designed. Electronic medical records of cancer patients who were admitted and tested for serum GM between March and June 2014 at a tertiary care university hospital were reviewed. During the study period, a single generic PTZ (C manufacturer, Korea) was used. Patients who received PTZ within 24 h prior to serum GM testing were enrolled. Age- and GM test date-matched non-PTZ patients were selected as controls. A total of 110 patients received PTZ within 24 h prior to serum GM testing during the study period. The GM optical density index (ODI) of the PTZ group did not vary significantly from that of the control group (p = 0.251). The percentage of false-positive patients in the PTZ group was also similar to that of the control group (p = 0.538). There was no statistical relationship between GM ODI titer and time interval from PTZ administration (p = 0.095) or cumulative PTZ dose (p = 0.416). In a case-control study that evaluated 220 patients, a generic PTZ in Korea was not related to GM false-positivity. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ko</LastName>
                    <ForeName>J-H</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peck</LastName>
                    <ForeName>K R</ForeName>
                    <Initials>KR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>W J</ForeName>
                    <Initials>WJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>J Y</ForeName>
                    <Initials>JY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>S Y</ForeName>
                    <Initials>SY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ha</LastName>
                    <ForeName>Y E</ForeName>
                    <Initials>YE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>C-I</ForeName>
                    <Initials>CI</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chung</LastName>
                    <ForeName>D R</ForeName>
                    <Initials>DR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jung</LastName>
                    <ForeName>C W</ForeName>
                    <Initials>CW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>E-S</ForeName>
                    <Initials>ES</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>J-H</ForeName>
                    <Initials>JH</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>04</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
            <NlmUniqueID>8804297</NlmUniqueID>
            <ISSNLinking>0934-9723</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000946">Antigens, Fungal</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008351">Mannans</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>11078-30-1</RegistryNumber>
                <NameOfSubstance UI="C012990">galactomannan</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>87-53-6</RegistryNumber>
                <NameOfSubstance UI="D010397">Penicillanic Acid</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>SE10G96M8W</RegistryNumber>
                <NameOfSubstance UI="D000078142">Tazobactam</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>X00B0D5O0E</RegistryNumber>
                <NameOfSubstance UI="D010878">Piperacillin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000946" MajorTopicYN="N">Antigens, Fungal</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001228" MajorTopicYN="N">Aspergillosis</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008351" MajorTopicYN="N">Mannans</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010397" MajorTopicYN="N">Penicillanic Acid</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010878" MajorTopicYN="N">Piperacillin</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000078142" MajorTopicYN="N">Tazobactam</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>01</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>4</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>4</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>3</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25894983</ArticleId>
            <ArticleId IdType="doi">10.1007/s10096-015-2370-5</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2004 Jun;4(6):349-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15172343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diagn Microbiol Infect Dis. 2008 Jan;60(1):117-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17889483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2008 Jun 15;46(12):1813-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18462102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2004 Mar 15;38(6):917-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14999641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Mal Infect. 2012 Jan;42(1):10-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22153703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mycoses. 1997 Dec;40(9-10):353-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9470421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bone Marrow Transplant. 2001 Sep;28(6):633-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11607782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Aug;55(4):e22-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22610929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2005 Oct;43(10):5214-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16207986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2007 Apr;45(4):1373</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17287325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2005 Sep;49(9):3984-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16127090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2005 Jan 15;40(2):333-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15655766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2012 Jul;67(7):1746-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22499998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2007 Aug;55(2):201-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17250896</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Jun;48(6):1989-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15155189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2014 Jun;52(6):2199-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24719434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2008 Jul;15(7):1132-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18463224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Mycol Case Rep. 2013 Dec 16;3:11-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24567893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mycoses. 2011 Nov;54(6):e883-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21623937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2004 Jul 15;39(2):289-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15307045</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2007 Sep;45(9):3141-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17670932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Intern Med. 2005 Nov;16(7):489-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16275542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2004 Nov;42(11):5362-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15528743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Dec 11;349(24):2366-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14668472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2011 Dec;49(12):4330-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21976760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2008 Feb;61(2):411-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18055488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2006 Feb;44(2):389-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16455889</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>